VR Logo

HCW Biologics Inc. (HCWB) download report


Healthcare | Biotechnology & Pharma Research

HCW Biologics Inc. (HCWB) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases.

IPO Date: 20-Jul-2021

Founder, CEO, Director & Sec.: Dr. Hing C. Wong Ph.D.

Chief Financial Officer: Ms. Rebecca Byam CPA, M.B.A.

Listing: NASDAQ: HCWB

Country: United States

Headquarters: Miramar, FL

Website: https://www.hcwbiologics.com

Key Facts

Market cap: $76.25 Mln

Revenue (TTM): $3.12 Mln

Earnings (TTM): $-12.56 Mln

Cash: $35.09 Mln

Total Debt: $0.00 Mln

Insider's Holding: 59.42%

Liquidity: Low

52 Week range: $1.89 - 7.78

Shares outstanding: 35,796,500

Stock Performance

Time Period HCW Biologics (HCWB) S&P BSE Sensex S&P Small-Cap 600
YTD-5.17-8.79-19.61
1 month1.85-4.72-9.38
3 months-29.03-12.34-15.04
1 Year--1.24-17.73
3 Years--10.015.82
5 Years--11.235.47
10 Years--11.779.50
As on 05-Jul-2022